attachment

What is diagnosis

Reading File
Finding Sources
Finding Sources
Searching PubMed

superficial thrombophlebitis forearm linear ecchymosis

Finding Sources
Finding Sources
Based on the clinical image and my analysis, here is the assessment:

Clinical Diagnosis: Superficial Thrombophlebitis (Mondor-type / IV-site related)

Most likely: Superficial thrombophlebitis of the forearm veins, with possible traumatic/iatrogenic ecchymosis from IV cannulation.

What the Image Shows

The image shows a long, linear, streak-like ecchymosis (bruising) running along the dorsal/lateral forearm from near the antecubital region down to the wrist, with:
  • A purple-violaceous discoloration following the course of a superficial vein (likely the cephalic vein)
  • A visible puncture mark near the wrist (consistent with IV cannula insertion site)
  • The patient appears to be in a clinical/hospital setting

Differential Diagnoses (in order of likelihood)

DiagnosisSupporting Features
Superficial thrombophlebitis (most likely)Linear streak following venous course, puncture mark, hospital setting
Traumatic ecchymosis post IV/phlebotomyPuncture site visible, linear tracking of extravasated blood
IV extravasation injuryHospital setting, linear pattern from cannula site
Chemical phlebitis (from IV drugs/fluids)Linear inflammation along vein, common post-infusion
LymphangitisLinear red streaking (though this appears more purpuric/ecchymotic than erythematous)

Most Probable Diagnosis

Given the hospital setting, visible puncture mark at the wrist, and linear ecchymosis tracking along the cephalic vein, the most likely diagnosis is:
Superficial thrombophlebitis / phlebitis secondary to IV cannulation or venipuncture, with tracking of blood (ecchymosis) along the subcutaneous vein.
This is a well-recognized complication of intravenous access. The bruising follows the vein because blood dissects along the vessel wall after a failed or prolonged cannulation attempt.

Management

  • Remove IV cannula if still in situ
  • Warm compresses to the affected area
  • Elevation of the limb
  • NSAIDs (e.g., ibuprofen) for pain/inflammation
  • Monitor for signs of infection (warmth, purulence, fever)
  • Reassure patient - ecchymosis typically resolves in 1-2 weeks

Important disclaimer: This is a visual assessment only and does not replace clinical examination. A clinician should assess the patient directly, palpate for a cord-like vein, check for warmth/tenderness, and consider Doppler ultrasound if deep vein thrombosis cannot be excluded.

Search for recent clinical guidelines on IV-related thrombophlebitis management

Reading File
Searching PubMed

\"thrombophlebitis\" AND \"peripheral intravenous catheter\" AND management

Finding Sources
Searching the Web

IV related thrombophlebitis clinical guidelines management 2023 2024 2025

Reading Article
Searching PubMed

\"peripheral intravenous catheter\" phlebitis prevention treatment

Finding Sources
Reading Article
Reading Article
Finding Sources
Reading Web Page

IV thrombophlebitis management treatment guidelines

Finding Sources
Reading File
Reading File
Excellent - comprehensive data from textbooks, guidelines, and PubMed. Here is the full synthesis:

IV-Related Thrombophlebitis: Recent Clinical Guidelines & Evidence


1. Definition & Classification

Superficial venous thrombosis (SVT) / superficial thrombophlebitis secondary to IV cannulation presents with the classic cardinal signs: rubor, calor, dolor, and tumor - a linear, erythematous, tender, swollen cord along a superficial vein. In hospitalized patients, SVT is most commonly caused by an indwelling peripheral IV catheter (PIVC).
  • Sabiston Textbook of Surgery, 21st ed., "Superficial Venous Thrombophlebitis"

2. Current Guidelines on Management

A. First-Line: Conservative (Local) Treatment

For localized, uncomplicated IV-site thrombophlebitis (the most common scenario in hospital patients):
InterventionDetails
Remove the IV catheterImmediate removal if still in situ
Warm compressesApplied locally 3-4x daily to reduce inflammation
NSAIDsOral ibuprofen or topical diclofenac gel for pain/inflammation
Limb elevationReduces edema and discomfort
CompressionCompression stockings for lower limb SVT
This conservative approach is sufficient for the vast majority of IV-cannula-related upper limb SVT, and anticoagulation is generally NOT indicated for simple cannula-related SVT.

B. 2025 ASH/ISTH Pediatric Guideline (New - June 2025)

The ASH/ISTH 2025 Pediatric Thrombosis Guidelines contain two key recommendations:
Recommendation 12a: For pediatric patients with SVT secondary to IV cannulation in the upper limb, the panel suggests NO anticoagulation rather than using anticoagulation. (Conditional recommendation; very low certainty evidence)
Recommendation 12b: For SVT not related to cannula (lower limb, cancer-associated, varicose veins), the panel suggests anticoagulation. (Conditional recommendation; very low certainty evidence)
The panel notes anticoagulation can be considered in select cases: symptomatic progression, PICC-related events, or cancer-associated SVT.

C. When Anticoagulation IS Required (Extensive SVT)

For larger-segment SVT (particularly lower extremity involving ≥5 cm of the great saphenous vein, or thrombus within 3 cm of the saphenofemoral junction), current surgical/vascular guidelines recommend:
  • Fondaparinux 2.5 mg SC daily for 6 weeks (preferred based on CALISTO trial evidence)
  • Enoxaparin 60 mg SC daily ("intermediate dose") for 6 weeks as alternative
  • Rivaroxaban 10 mg daily x 45 days - shown non-inferior to fondaparinux in the SURPRISE trial (oral option, more convenient)
  • Sabiston Textbook of Surgery, "Superficial Venous Thrombophlebitis"
For upper extremity IV-infusion phlebitis specifically (brachial vein), the Rosen's Emergency Medicine textbook states:
"No study has demonstrated clear benefit for systemic anticoagulation of brachial vein thrombosis. It is reasonable to treat these clots similarly to superficial thrombophlebitis of the leg."
  • Rosen's Emergency Medicine, 10th ed., "Upper Extremity Venous Thromboses"

D. Australian Commission Clinical Care Standard (ACSQHC, 2023)

  • PIVCs should be replaced based on clinical indication (signs of phlebitis/infection), not routine scheduled replacement
  • The device site should be assessed at least once daily
  • PIVC should be removed immediately when signs of thrombophlebitis appear
  • Forearm sites preferred over dorsum of hand (lower phlebitis risk)
  • Avoid cubital fossa sites if possible; re-site as soon as appropriate

3. Prevention - What the Evidence Says

A major 2024 systematic review (Dobrescu et al., Clin Infect Dis, PMID 38593192) analyzed 105 studies and 24 IPC interventions:
  • Scheduled catheter removal may lower phlebitis incidence vs. clinically-indicated removal (RR 0.74; 10 RCTs) - but evidence certainty was low
  • Wearing gloves at insertion reduces adverse events (RR 0.52)
  • Chlorhexidine skin prep reduces phlebitis scores in neonates
  • For most other preventive measures, evidence was insufficient to make strong recommendations
  • The review concluded: "adherence to standard precaution measures and documentation remain the most important principles"
A 2022 RCT analysis (Simões et al., PMID 35724261, n=1,319) identified key modifiable risk factors for PIVC-related phlebitis:
Risk FactorRecommendation
Hand dorsum cannulationAvoid dorsal hand veins; use forearm
Reduced patient mobilityEncourage/promote mobility
Amoxicillin-clavulanate infusionMonitor closely; consider central access
Omeprazole sodium IVMonitor closely
Pain at siteTake pain complaints seriously - early predictor

4. Phlebitis Grading Scale (VIP Scale - Clinical Tool)

GradeSignsAction
0No symptomsObserve
1Slight pain/redness near IV siteObserve
2Pain, erythema, swellingResite
3Pain, erythema, swelling, palpable cordResite, document
4Pain + cord >1 inch, purulentResite, treat infection
5All above + feverTreat as septic thrombophlebitis

5. Summary of Key Guideline Recommendations

Clinical ScenarioRecommendationSource
IV cannula-related upper limb SVTNo anticoagulation; remove cannula, warm compress, NSAIDsASH/ISTH 2025
Symptomatic SVT progression or PICC-relatedConsider anticoagulationASH/ISTH 2025
Lower limb SVT ≥5 cm GSVFondaparinux 2.5 mg/day x 6 weeks or rivaroxaban 10 mg/day x 45 daysSabiston 2024 / SURPRISE trial
SVT within 3 cm of saphenofemoral junctionAnticoagulation (same as above)Sabiston 2024
Septic/suppurative thrombophlebitisAntibiotics + surgical excision of veinConsensus
PIVC site assessmentMinimum daily; remove immediately if phlebitis signsACSQHC Standard 2023

Disclaimer: These guidelines are for educational reference. Clinical decisions should integrate the individual patient's full clinical context, comorbidities, and a treating clinician's direct assessment.

AGE with s . dehydration

Reading File
Finding Sources
Finding Sources
Searching PubMed

\"acute gastroenteritis\" AND dehydration AND management

Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Excellent - comprehensive data gathered. Here is the full structured clinical guide:

Acute Gastroenteritis (AGE) with Some Dehydration


1. Understanding "Some Dehydration" (WHO Classification)

The WHO classifies dehydration in AGE into three tiers. "Some dehydration" corresponds to moderate dehydration (5-10% body weight loss):
FeatureNo DehydrationSome DehydrationSevere Dehydration
General conditionWell, alertRestless, irritableLethargic / unconscious
EyesNormalSunkenVery sunken & dry
TearsPresentReducedAbsent
Mouth/tongueMoistDryVery dry
ThirstDrinks normallyDrinks eagerly, thirstyDrinks poorly / unable
Skin pinchReturns immediatelyReturns slowly (<2 sec)Returns very slowly (>2 sec)
Fluid deficit<5%5-10%>10%
WHO PlanPlan APlan BPlan C
2 or more signs in the "some dehydration" column = Plan B
  • Rosen's Emergency Medicine, 10th ed., "Oral Rehydration Therapy"; Tintinalli's Emergency Medicine, 10th ed., "Treatment"

2. Management: WHO Plan B (Some/Moderate Dehydration)

Step 1 - Oral Rehydration Therapy (ORT)

ORS volume = 75 mL/kg over 4 hours (or 50-80 mL/kg depending on assessment)
FormulaMethod
Mild (3-5%)30-50 mL/kg ORS over 4 hours
Moderate/Some (6-9%)60-80 mL/kg ORS over 4 hours
Replace ongoing losses+10 mL/kg per stool; +2 mL/kg per vomit episode
Administer 25% of the calculated volume per hour for 4 hours, then reassess.
ORS composition (WHO low-osmolarity, <270 mOsm/L):
  • Sodium: 75 mmol/L
  • Glucose: 75 mmol/L
  • Chloride: 65 mmol/L
  • Potassium: 20 mmol/L
  • Citrate: 10 mmol/L
  • Osmolarity: 245 mOsm/L
ORT is effective even if the patient continues to vomit - administer in small, frequent amounts (e.g., 5 mL every 1-2 min by spoon in infants).
  • Rosen's Emergency Medicine, "Oral Rehydration Therapy"

Step 2 - Reassess After 4 Hours

  • If improved (no dehydration signs) → move to Plan A (maintenance at home)
  • If still "some dehydration" → repeat Plan B
  • If worsened to severe dehydration → escalate to Plan C (IV fluids)

3. When to Switch to IV Fluids (Plan C escalation)

Switch from ORT to IV fluids if:
  • Severe dehydration or shock (>10% loss, cold peripheries, prolonged CRT)
  • Persistent vomiting despite small-volume ORT
  • Altered consciousness / lethargy
  • Suspected intestinal obstruction or acute abdomen
  • Sodium derangement (hypernatremia or hyponatremia)
  • ORT failure after 4-hour trial
IV fluid of choice:
  • Ringer's Lactate (Hartmann's solution) - preferred
  • Normal saline (0.9% NaCl) as alternative
  • Severe dehydration IV regimen: 100 mL/kg RL over 3 hours in children (30 mL/kg fast bolus over 30 min, then 70 mL/kg over 2.5 hours); reassess every 30 min
"For patients with severe dehydration, isotonic intravenous fluids should be used, and lactated Ringer solution is the preferred commercially available option."
  • Red Book 2021, "Vibrio cholerae"

4. Additional Treatment Measures

Antiemetics

  • Ondansetron (oral/IV) - reduces vomiting, reduces need for IV fluids, reduces ED admission
    • Children: 0.15 mg/kg PO/IV once (max 8 mg)
    • Adults: 4-8 mg PO/IV
  • Metoclopramide as second line
Antiemetics reduce vomiting, ED length of stay, and admission need. - Tintinalli's EM

Zinc Supplementation (Children, especially <5 yrs in low-income settings)

  • 20 mg/day x 10-14 days (>6 months)
  • 10 mg/day x 10-14 days (<6 months)
  • Reduces duration and severity of diarrhea

Antimotility Agents

  • Loperamide - safe in adults for mild-moderate nonbloody diarrhea; reduces illness duration
  • AVOID in: children, dysentery (bloody diarrhea + fever), suspected STEC O157 infection

Probiotics

  • Some evidence for Lactobacillus rhamnosus GG and Saccharomyces boulardii reducing duration by ~1 day in children (adjunctive use)

Feeding / Nutrition

  • Do NOT withhold food - early refeeding encouraged once vomiting controlled
  • Continue breastfeeding in infants throughout illness
  • Age-appropriate diet should resume as soon as tolerated
  • Avoid high-sugar drinks (juice, sports drinks, sodas) as sole replacement - they are not suitable ORS substitutes

5. Antibiotics - When to Use

Most AGE is viral or self-limited bacterial - empiric antibiotics are not routinely indicated.
Use antibiotics when (IDSA 2017 guidelines):
IndicationAntibiotic
Infants <3 months with bloody diarrheaAmpicillin + gentamicin or cefotaxime
Immunocompromised with severe illnessEmpiric fluoroquinolone or azithromycin
Suspected Shigella (fever + bloody diarrhea)Azithromycin 500 mg OD x 3 days
Travelers' diarrhea with feverCiprofloxacin 500 mg BD x 3-5 days OR azithromycin 500 mg OD x 3 days
Confirmed CampylobacterAzithromycin (first line - due to fluoroquinolone resistance)
Confirmed Salmonella typhiAzithromycin, ceftriaxone, or fluoroquinolone (per sensitivity)
NEVER give antibiotics if STEC (O157:H7) is suspected - increases risk of Hemolytic Uremic Syndrome (HUS).

6. Investigations

InvestigationWhen Indicated
Electrolytes, BUN, CreatinineSigns of systemic illness, severe dehydration, prolonged illness, very young/elderly
Blood glucoseChildren (risk of hypoglycemia)
Stool culture / PCR multipanelBloody diarrhea, fever >38.5°C, >1 week illness, immunocompromised, traveler
CBCSystemic symptoms, comorbidities
Stool ova & parasites>2 weeks illness, travelers, immunocompromised
Urinalysis / urine SGAssess hydration status
Routine stool testing is NOT indicated for uncomplicated watery diarrhea. - Tintinalli's EM, 10th ed.

7. Admission Criteria

Admit / observe if:
  • Severe dehydration unresponsive to ORT
  • Persistent vomiting making ORT impossible
  • Altered mental status
  • Systemic symptoms (high fever, signs of sepsis)
  • Significant comorbidities (immunocompromised, IBD, renal failure)
  • Infants <6 months with any dehydration
  • Failure to improve after 4-hour Plan B trial
  • Bloody diarrhea with toxaemia
Safe for discharge (Plan A at home) if:
  • Tolerating ORS
  • No signs of dehydration after treatment
  • Caregiver able and willing to continue ORT at home
  • Clear follow-up instructions given

8. Patient/Caregiver Education (Plan A - Discharge Instructions)

  1. Give extra ORS or fluids after every loose stool: 50-100 mL for infants, 100-200 mL for older children/adults
  2. Continue feeding normally - do not restrict diet
  3. Return immediately if: child becomes more unwell, unable to drink, bloody diarrhea, high fever, or no improvement after 2 days
  4. Hand hygiene - frequent handwashing to prevent household spread
  5. Zinc supplementation course in children (developing world settings)

Clinical note: "Some dehydration" on WHO assessment mandates supervised Plan B ORT. Most patients respond well within 4 hours without IV fluids. The key is frequent reassessment and early escalation if ORT fails.
  • Sources: Tintinalli's Emergency Medicine 10th ed.; Rosen's Emergency Medicine 10th ed.; Red Book 2021 (AAP); WHO IMCI guidelines

Rx

Asking for Preferences
Please go ahead and type the patient's weight (in kg), and also let me know if there is any vomiting, bloody diarrhea, or fever so I can tailor the prescription correctly.

∆- AGaE with s.dehydration rx.

Here is the standard prescription for AGE with Some Dehydration in an adult:

℞ — AGE with Some Dehydration (Adult)


💧 Rehydration (Priority #1)

ORS (Oral Rehydration Solution)
  • WHO low-osmolarity ORS — 1 sachet in 200 mL clean water
  • Give 750 mL – 1000 mL over 4 hours (sip frequently)
  • Replace ongoing losses: 200–400 mL after each loose stool
  • If vomiting: give small sips every 5 minutes continuously

💊 Drug Prescription

Rx

1. Tab. Ondansetron 4 mg
   — 1 tab TDS (or SOS with vomiting)
   — × 3 days
   [Antiemetic — reduces vomiting, aids ORS intake]

2. Tab. Metronidazole 400 mg
   — 1 tab TDS after food
   — × 5 days
   [For protozoal/anaerobic bacterial cause]

3. Tab. Racecadotril 100 mg
   — 1 tab TDS before food
   — × 3–5 days
   [Antisecretory — reduces stool output without paralysing gut]

4. Tab. Domperidone 10 mg
   (alternative antiemetic if Ondansetron unavailable)
   — 1 tab TDS 30 min before meals
   — × 3 days

5. ORS Sachet
   — 1 sachet in 200 mL water
   — Drink 200–400 mL after every loose stool
   — Continue until diarrhea stops

6. Tab. Pantoprazole 40 mg
   — 1 tab OD before breakfast
   — × 5 days
   [For gastric protection / associated nausea/dyspepsia]

🔴 If IV Access Required (vomiting, cannot tolerate oral)

IV Line — Insert 18G cannula

1. IV Ringer's Lactate (RL) 1 Litre
   — Run at 500 mL/hour × 2 hours
   — Then reassess hydration status

2. Inj. Ondansetron 4 mg IV / slow push
   — TDS × 2–3 days (or until oral tolerated)

3. Inj. Pantoprazole 40 mg IV
   — OD × 2 days

4. Oral rehydration to continue once vomiting controlled

🚫 Avoid

DrugReason
LoperamideAvoid if fever or suspected dysentery
Antibiotics (empiric)Most AGE is viral; not routinely needed
NSAIDsWorsen GI mucosa
Codeine-containing antidiarrhoealsRisk of paralytic ileus

🥗 Diet Advice (BRAT + modifications)

  • Resume eating early — do not fast
  • Bland foods: rice, banana, boiled potato, toast, curd/yogurt
  • Avoid: spicy food, dairy (except yogurt), raw vegetables, alcohol, caffeine
  • Increase fluid intake throughout the day

⚠️ Red Flags — Return Immediately If:

  • Bloody or black stools
  • High fever (>38.5°C)
  • No urine output for >6 hours
  • Confusion, extreme weakness
  • Vomiting blood
  • No improvement after 48 hours

📋 Follow-Up

  • Review after 48 hours
  • If no improvement: stool culture / microscopy, CBC, electrolytes
  • Consider referral if symptoms persist >5–7 days

Note: This is a general adult prescription framework. Adjust doses for renal/hepatic impairment, pregnancy, or significant comorbidities. Metronidazole should only be continued if protozoal/anaerobic cause is suspected or confirmed.

∆- s anaemia

Finding Sources
Finding Sources
Asking for Preferences
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Here is the complete prescription:

℞ — Severe Anaemia (Adult)


Step 1 - Immediate Assessment

Before prescribing, classify severity by Hb level:
Hb LevelClassificationAction
10–12 g/dL (F) / 10–13 g/dL (M)MildOral iron + treat cause
8–10 g/dLModerateOral iron ± IV iron
<8 g/dLSevereIV iron ± transfusion
<7 g/dL or symptomaticCriticalUrgent blood transfusion

Step 2 - Immediate Management (If Hb <7 or Symptomatic)

EMERGENCY ORDERS

1. IV Access — 18G cannula (2 large-bore if actively bleeding)

2. Blood investigations STAT:
   — CBC / FBC, Peripheral blood smear
   — Serum Iron, TIBC, Ferritin (IDA workup)
   — Serum B12, Folate levels
   — Reticulocyte count
   — LFT, RFT, Urine R/E
   — Blood grouping & cross-match (2 units)

3. Packed Red Blood Cell (PRBC) Transfusion
   — Indication: Hb <7 g/dL, OR Hb <8 with:
     angina / cardiac compromise / severe dyspnoea /
     hypotension / active bleeding / syncope
   — Give: 1 unit PRBC over 3–4 hours
   — Check Hb after each unit; target Hb 8–10 g/dL
   — Pre-medicate: Inj. Chlorpheniramine 10 mg IV slow push
     (to prevent transfusion reaction)
   — Monitor: BP, pulse, SpO2, temperature every 30 min during
     transfusion

Step 3 - Oral Iron Therapy (Mainstay for IDA)

Rx

1. Tab. Ferrous Sulphate 200 mg (65 mg elemental iron)
   — 1 tab BD–TDS on empty stomach (or with food if GI upset)
   — × 3–6 months (continue 3 months after Hb normalises
     to replenish stores)

   OR

   Tab. Ferrous Fumarate 200 mg
   — 1 tab BD
   — × 3–6 months

2. Tab. Folic Acid 5 mg
   — 1 tab OD
   — × 3–6 months
   [Co-deficiency common; enhances erythropoiesis]

3. Tab. Vitamin C (Ascorbic Acid) 500 mg
   — 1 tab OD with iron tablet
   — × 3 months
   [Enhances non-haem iron absorption by ~30%]

4. Tab. Vitamin B12 (Cyanocobalamin) 500 mcg
   — 1 tab OD
   — × 3 months
   [If B12 deficiency suspected / macrocytic component]

Step 4 - IV Iron (If oral not tolerated / malabsorption)

IV Iron Sucrose (Venofer)
— 200 mg in 100 mL NS over 30 minutes
— 2–3 infusions per week (total dose calculated by
  Ganzoni formula or standard dosing)
— Maximum single dose: 200–300 mg

OR

Ferric Carboxymaltose (Ferinject)
— 500–1000 mg IV over 15 min (single infusion)
— Preferred in outpatient setting (fewer infusions needed)

Pre-medication before IV iron:
— Inj. Chlorpheniramine 10 mg IV slow push (prophylaxis)
— Test dose: give first 25 mg over 15 min, observe 15 min,
  then give remainder if no reaction

Step 5 - Treat the Underlying Cause

CauseTreatment
Iron Deficiency (IDA)Ferrous sulphate + treat source of blood loss
B12 / Folate deficiencyB12 + Folic acid supplementation
Hookworm / parasitesTab. Albendazole 400 mg single dose
MalariaTreat per malaria protocol
H. pylori (GI blood loss)Triple therapy eradication
CKD / renal anaemiaEPO + IV iron
MenorrhagiaGynaecological referral
GI bleedGI workup, endoscopy

Step 6 - Diet Counselling

Iron-rich foods:
  • Red meat, organ meat (liver, kidney)
  • Leafy green vegetables (spinach, drumstick leaves)
  • Legumes (lentils, beans, chickpeas)
  • Fortified cereals, jaggery, dates, raisins
Enhance absorption:
  • Take iron with Vitamin C (citrus juice, amla)
Reduce absorption (avoid with iron tablet):
  • Tea, coffee, milk, calcium supplements, antacids
  • Take these 2 hours apart from iron

Monitoring & Follow-Up

TimelineWhat to Check
7–10 daysReticulocyte count (should rise = response confirmed)
4–6 weeksRepeat Hb / FBC (expect +1–2 g/dL rise)
3 monthsHb should normalise
6 monthsSerum ferritin (stores replenished)

⚠️ Red Flags — Urgent Review / Referral

  • No rise in Hb after 4 weeks of treatment → reconsider diagnosis
  • Pancytopenia → bone marrow biopsy (aplastic anaemia / malignancy)
  • Haemolysis (jaundice + anaemia) → haematology referral
  • Hb <5 g/dL → urgent transfusion regardless of symptoms

Sources: Symptom to Diagnosis (4th ed.); Goodman & Gilman's Pharmacological Basis of Therapeutics; Goldman-Cecil Medicine; WHO guidelines on anaemia management.
This is a shared conversation. Sign in to Orris to start your own chat.